Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02779335 · ClinicalTrials.gov registry record · NA
Enteral Formula Tolerance in Pediatric Patients
A NA study, sponsored by Société des Produits Nestlé (SPN).
- Completed
- Registry status
- NA
- Development phase
- 22
- Enrollment target
NCT02779335 is a NA study that has completed, run by Société des Produits Nestlé (SPN). The registered enrollment target is 22 participants.
The verdict
NCT02779335, a NA study, has completed, sponsored by Société des Produits Nestlé (SPN).
- COMPLETED
- Registry status
- NA
- Development phase
- 22 participants
- Enrollment target
Study Summary
The purpose of this prospective study seeks to assess ability to achieve enteral feeding goals with standard polymeric enteral formula in a stable, pediatric tube-fed population.
Interventions
- OTHER Enteral Formula
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 22 participants |
| Start Date | 2016-05 |
| Est. Completion | 2016-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02779335
The ClinicalTrials.gov registry entry for NCT02779335 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 22 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Société des Produits Nestlé (SPN), which has 53 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Enteral Formula is the first listed.
NCT02779335 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02779335 about?
NCT02779335 is a clinical study titled "Enteral Formula Tolerance in Pediatric Patients". The purpose of this prospective study seeks to assess ability to achieve enteral feeding goals with standard polymeric enteral formula in a stable, pediatric tube-fed population.
What is the current status of trial NCT02779335?
This trial is currently completed. It is a NA study. The enrollment target is 22 participants. The study started on 2016-05. Estimated completion is 2016-10.
What interventions are being tested in trial NCT02779335?
The interventions under investigation include: Enteral Formula (OTHER).
Who is sponsoring clinical trial NCT02779335?
This trial is sponsored by Société des Produits Nestlé (SPN), which has 53 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.